Table 2.
Patients Characteristics
| Sample name | Mel 60/30 or Nevus 60/30 | Age | Age range | Gender | Diagnosis | Site | T Stage | N Stage | M Stage | Stage Group at Diagnosis- AJCC 6th Ed. |
|---|---|---|---|---|---|---|---|---|---|---|
| PM7 | Mel 30 | 21 | 20-29 | M | Melanoma, invasive and insitu, arising in association with a nevus | Trunk | cT1* | pN0 | cM0 | Unknown |
| PM2 | Mel 30 | 26 | 20-29 | M | Superficial spreading melanoma, invasive and in situ | Back | pT1b | pN1a | cM0 | 3B |
| PM3 | Mel 30 | 26 | 20-29 | F | Melanoma, superficial spreading in radial growth phase & vertical, epithelioid, nevoid and balloon cell | Scapula | pT2b | pN0 | cM0 | 2A |
| PM6 | Mel 30 | 28 | 20-29 | F | Superficial spreading melanoma, invasive | Thigh | pT1b | pN0 | cM0 | 1B |
| PM8 | Mel 30 | 28 | 20-29 | M | Highly atypical spitzoid neoplasm | Arm | n/a | n/a | n/a | n/a |
| PM4 | Mel 30 | 28 | 20-29 | F | Superficial spreading melanoma, invasive | Shin | pT1a | pN0 | cM0 | 1A |
| PM11112 | Mel 30 | 29 | 20-29 | F | Superficial spreading (Spitzoid) melanoma, insitu & invasive | Thigh | pT1a | pN0 | cM0 | 1A |
| PM5 | Mel 30 | 29 | 20-29 | M | Melanoma in situ (arising in compound melanocytic nevus) | Abdomen | pTis | cN0 | cM0 | 0 |
| PM9 | Mel 30 | 29 | 20-29 | F | Invasive and in situ melanoma, nodular. Note: Description of superficial spreading also in synopsis but registry only codes final diagnoses. | Buttock | pT4b | pN3 | cM1c | 4 |
| PM10 | Mel 30 | 29 | 20-29 | M | Superficial spreading melanoma, insitu and invasive | Scalp | pT1a | cN0 | cM0 | 1A |
| PN1 | Nevus 30 | 12 | 10-19 | F | Compound, predominantly intradermal melanocytic nevus | Forehead | n/a | n/a | n/a | n/a |
| PN2 | Nevus 30 | 14 | 10-19 | M | Compound predominantly intradermal melanocytic nevus with architectural features of congenital onset | Scalp | n/a | n/a | n/a | n/a |
| PN3 | Nevus 30 | 26 | 20-29 | F | Compound melanocytic nevus with features of a congenital nevus, architectural disorder and mild cytologic atypia (aka Clark's nevus with features of congenital onset). | Back | n/a | n/a | n/a | Unknown |
| AM1 | Mel 60 | 64 | 60-69 | F | Melanoma, invasive, nevoid type. | Leg | pT2a | pN0 | cM0 | 1B |
| AM2 | Mel 60 | 69 | 60-69 | M | Superficial spreading (outside path) and Nevoid Melanoma, invasive | Ear | pT4b | pN3 | cM0 | 3C |
| AM3 | Mel 60 | 69 | 60-69 | M | Desmoplastic melanoma, invasive | Forehead | pT3a | pN0 | cM0 | 2A |
| AM10 | Mel 60 | 72 | 70-79 | M | Malignant melanoma in situ arising in a compound dysplastic nevus | Back | pTis | cN0 | cM0 | 0 |
| AM4 | Mel 60 | 73 | 70-79 | M | Nodular melanoma, invasive and insitu | Calf | pT4b | pN3 | cM0 | 3C |
| AM5 | Mel 60 | 78 | 70-79 | F | Melanoma, insitu and invasive | Foot | pT2b | pN2c | cM0 | 3B |
| AM6 | Mel 60 | 79 | 70-79 | M | Lentingo malignant melanoma in situ with focus invasive melanoma | Back | pT1a | cN0 | cM0 | 1A |
| AM9 | Mel 60 | 79 | 70-79 | M | Invasive melanoma (&Melanoma in Situ arising in a background of dysplastic nevus | Back | pT1a | cN0 | cM0 | 1A |
| AM7 | Mel 60 | 82 | 80-89 | F | Desmoplastic melanoma with associated lentiginous component | Arm | pT4a | pN0 | cM0 | 2B |
| AM8 | Mel 60 | 86 | 80-89 | M | Nodular melanoma (3% in situ) | Flank | pT2a | cN0 | cM0 | 1B |
| AN1 | Nevus 60 | 62 | 60-69 | F | Compound, predominantly intradermal melanocytic nevus with architectural features of congenital onset | Back | n/a | n/a | n/a | n/a |
| AN2 | Nevus 60 | 63 | 60-69 | M | Compound predominantly intradermal melanocytic nevus with architectural features of congenital onset | Flank | n/a | n/a | n/a | n/a |
| AN3 | Nevus 60 | 68 | 60-69 | M | Compound melanocytic nevus with moderate cytological atypia and congenital features. | Deltoid | n/a | n/a | n/a | n/a |
PM = pediatric and young adult melanoma (<30 yrs);AM = adult melanoma (>60 yrs);PN = pediatric and young adult nevus(<30 yrs); AN = adult nevus(>60 yrs); Mel 60: adult melanoma (>60 yrs); Mel 30: pediatric and young adult melanoma (<30 yrs); Nevus 60: adult nevus(>60 yrs); Nevus 30: pediatric and young adult nevus(<30 yrs). TNM Staging:regardless of year of diagnosis, all cases staged according to AJCC 6th Edition. P:pathologic staging; c: clinical staging. * Not able to stage T further as Clarks level missing in original path report.